Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Industry: Pharma & Healthcare

Published Date: 2025-03-28

Pages: 121 Pages

Report ld: 4675429

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Industry Insights:

Urokinase Research：CAGR of 4.7% during the forecast period

Urokinase Market Size(US$)

CAGR 2025-2031

5.2%

Market Size,2031

USD 70.6

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 52.1 million

Market Forecast in 2031(Value)

US$ 70.6 million

CAGR

5.2%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

In 2024, the global market size of Urokinase was estimated to be worth US$ 49.8 million and is forecast to reach approximately US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.

Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.

Global key players of urokinase include Syner-Med, LIVZON, Wanhua Biochem, etc. The top three players hold a share about 50%. China is the largest market of Urokinase, holding a share about 56%, followed by Europe and North America.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Urokinase, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urokinase.

The Urokinase market size, estimations, and forecasts are provided in terms of sales volume (BIU) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Urokinase market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Urokinase manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

By Company

Syner-Med

Wanhua Biochem

Jiangxi Haoran Bio-Pharma

Jiangsu Aidea Pharmaceutical

Techpool

Microbic Biosystems

LIVZON

Segment by Type

Urokinase Powder

Urokinase Solution

Segment by Application

Hospital

Clinic

Others

By Region

North America

United States

Canada

Asia-Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Rest of Asia-Pacific

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Rest of Europe

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Urokinase in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 3: Detailed analysis of Urokinase manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Urokinase sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.

Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.

Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: Research Findings and Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Urokinase Product Introduction

1.2 Market by Type

1.2.1 Global Urokinase Market Size Growth Rate by Type (2020 VS 2024 VS 2031)

1.2.2 Urokinase Powder

1.2.3 Urokinase Solution

1.3 Market by Application

1.3.1 Global Urokinase Market Size Growth Rate by Application (2020 VS 2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Urokinase Market Size Estimates and Forecasts

2.1.1 Global Urokinase Revenue 2020-2031

2.1.2 Global Urokinase Sales 2020-2031

2.2 Urokinase Market Size by Region: 2024 Versus 2031

2.3 Urokinase Sales by Region (2020-2031)

2.3.1 Global Urokinase Sales by Region: 2020-2025

2.3.2 Global Urokinase Sales Forecast by Region (2026-2031)

2.3.3 Global Urokinase Sales Market Share by Region (2020-2031)

2.4 Urokinase Market Estimates and Projections by Region (2026-2031)

2.4.1 Global Urokinase Revenue by Region: 2020-2025

2.4.2 Global Urokinase Revenue Forecast by Region (2026-2031)

2.4.3 Global Urokinase Revenue Market Share by Region (2020-2031)

3 Market Segments

3.1 Breakdown Data by Type

3.1.1 Global Urokinase Sales by Type (2020-2031)

3.1.1.1 Global Urokinase Sales Volume by Type (2020-2031)

3.1.1.2 Global Urokinase Sales Market Share by Type (2020-2031)

3.1.2 Global Urokinase Revenue by Type (2020-2031)

3.1.2.1 Global Urokinase Revenue by Type (2020-2031)

3.1.2.2 Global Urokinase Revenue Market Share by Type (2020-2031)

3.1.3 Urokinase Average Selling Price (ASP) by Type (2020-2031)

3.2 Breakdown Data by Application

3.2.1 Global Urokinase Sales by Application (2020-2031)

3.2.1.1 Global Urokinase Sales Volume by Application (2020-2031)

3.2.1.2 Global Urokinase Sales Market Share by Application (2020-2031)

3.2.2 Global Urokinase Revenue by Application (2020-2031)

3.2.2.1 Global Urokinase Revenue by Application (2020-2031)

3.2.2.2 Global Urokinase Revenue Market Share by Application (2020-2031)

3.2.3 Urokinase Average Selling Price (ASP) by Application (2020-2031)

3.3 by Type and by Application Crossing Analysis

3.3.1 Urokinase Powder of Urokinase Revenue Market Share by Application

3.3.2 Urokinase Solution of Urokinase Revenue Market Share by Application

4 Global Urokinase by Manufacturers

4.1 Global Top Urokinase Manufacturers by Sales (2020-2025)

4.1.1 Global Urokinase Sales by Manufacturer (2020-2025)

4.1.2 Global Urokinase Sales Market Share by Manufacturer (2020-2025)

4.2 Global Top Urokinase Manufacturers by Revenue (2020-2025)

4.2.1 Global Urokinase Revenue by Manufacturer (2020-2025)

4.2.2 Global Urokinase Revenue Share by Manufacturer (2020-2025)

4.3 Global Urokinase Price by Manufacturer (2020-2025)

4.4 Competitive Landscape

4.4.1 Key Urokinase Manufacturers Covered: Ranking by Revenue

4.4.2 Global Urokinase Market Concentration Ratio (CR5 and HHI) & (2020-2025)

4.4.3 Global Urokinase Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.5 Global Urokinase Manufacturing Base Distribution, Product Type

4.5.1 Urokinase Manufacturers Manufacturing Base Distribution, Headquarters

4.5.2 Date of International Manufacturers Enter into Urokinase Market

4.5.3 Manufacturers Urokinase Product Type and Application

4.5.4 Urokinase Powder Market Sales of Urokinase by Manufacturer

4.5.5 Urokinase Solution Market Sales of Urokinase by Manufacturer

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

5 Company Profiles

5.1 Syner-Med

5.1.1 Syner-Med Company Information

5.1.2 Syner-Med Description, Business Overview

5.1.3 Syner-Med Urokinase Products Offered

5.1.4 Syner-Med Urokinase Sales, Revenue and Gross Margin (2020-2025)

5.1.5 Syner-Med Urokinase Sales by Product in 2024

5.1.6 Syner-Med Urokinase Sales by Application in 2024

5.1.7 Syner-Med Urokinase Sales by Geographic Area in 2024

5.1.8 Syner-Med Recent Developments

5.2 Wanhua Biochem

5.2.1 Wanhua Biochem Company Information

5.2.2 Wanhua Biochem Description, Business Overview

5.2.3 Wanhua Biochem Urokinase Products Offered

5.2.4 Wanhua Biochem Urokinase Sales, Revenue and Gross Margin (2020-2025)

5.2.5 Wanhua Biochem Urokinase Sales by Product in 2024

5.2.6 Wanhua Biochem Urokinase Sales by Application in 2024

5.2.7 Wanhua Biochem Urokinase Sales by Geographic Area in 2024

5.2.8 Wanhua Biochem Recent Developments

5.3 Jiangxi Haoran Bio-Pharma

5.3.1 Jiangxi Haoran Bio-Pharma Company Information

5.3.2 Jiangxi Haoran Bio-Pharma Description, Business Overview

5.3.3 Jiangxi Haoran Bio-Pharma Urokinase Products Offered

5.3.4 Jiangxi Haoran Bio-Pharma Urokinase Sales, Revenue and Gross Margin (2020-2025)

5.3.5 Jiangxi Haoran Bio-Pharma Urokinase Sales by Product in 2024

5.3.6 Jiangxi Haoran Bio-Pharma Urokinase Sales by Application in 2024

5.3.7 Jiangxi Haoran Bio-Pharma Urokinase Sales by Geographic Area in 2024

5.3.8 Jiangxi Haoran Bio-Pharma Recent Developments

5.4 Jiangsu Aidea Pharmaceutical

5.4.1 Jiangsu Aidea Pharmaceutical Company Information

5.4.2 Jiangsu Aidea Pharmaceutical Description, Business Overview

5.4.3 Jiangsu Aidea Pharmaceutical Urokinase Products Offered

5.4.4 Jiangsu Aidea Pharmaceutical Urokinase Sales, Revenue and Gross Margin (2020-2025)

5.4.5 Jiangsu Aidea Pharmaceutical Urokinase Sales by Product in 2024

5.4.6 Jiangsu Aidea Pharmaceutical Urokinase Sales by Application in 2024

5.4.7 Jiangsu Aidea Pharmaceutical Urokinase Sales by Geographic Area in 2024

5.4.8 Jiangsu Aidea Pharmaceutical Recent Developments

5.5 Techpool

5.5.1 Techpool Company Information

5.5.2 Techpool Description, Business Overview

5.5.3 Techpool Urokinase Products Offered

5.5.4 Techpool Urokinase Sales, Revenue and Gross Margin (2020-2025)

5.5.5 Techpool Urokinase Sales by Product in 2024

5.5.6 Techpool Urokinase Sales by Application in 2024

5.5.7 Techpool Urokinase Sales by Geographic Area in 2024

5.5.8 Techpool Recent Developments

5.6 Microbic Biosystems

5.6.1 Microbic Biosystems Company Information

5.6.2 Microbic Biosystems Description, Business Overview

5.6.3 Microbic Biosystems Urokinase Products Offered

5.6.4 Microbic Biosystems Urokinase Sales, Revenue and Gross Margin (2020-2025)

5.6.5 Microbic Biosystems Urokinase Sales by Product in 2024

5.6.6 Microbic Biosystems Urokinase Sales by Application in 2024

5.6.7 Microbic Biosystems Urokinase Sales by Geographic Area in 2024

5.6.8 Microbic Biosystems Recent Developments

5.7 LIVZON

5.7.1 LIVZON Company Information

5.7.2 LIVZON Description, Business Overview

5.7.3 LIVZON Urokinase Products Offered

5.7.4 LIVZON Urokinase Sales, Revenue and Gross Margin (2020-2025)

5.7.5 LIVZON Urokinase Sales by Product in 2024

5.7.6 LIVZON Urokinase Sales by Application in 2024

5.7.7 LIVZON Urokinase Sales by Geographic Area in 2024

5.7.8 LIVZON Recent Developments

6 North America

6.1 North America Urokinase Market Size YoY Growth 2020-2031

6.2 North America Urokinase Market Facts & Figures by Country

6.2.1 North America Urokinase Sales by Country (2020-2031)

6.2.2 North America Urokinase Revenue by Country (2020-2031)

6.3 North America Urokinase Sales by Type (2020-2025)

6.4 North America Urokinase Sales by Application (2020-2025)

7 Asia-Pacific

7.1 Asia-Pacific Urokinase Market Size YoY Growth 2020-2031

7.2 Asia-Pacific Urokinase Market Facts & Figures by Region

7.2.1 Asia-Pacific Urokinase Sales by Region (2020-2031)

7.2.2 Asia-Pacific Urokinase Revenue by Region (2020-2031)

7.3 Asia-Pacific Urokinase Sales by Type (2020-2025)

7.4 Asia-Pacific Urokinase Sales by Application (2020-2025)

8 Europe

8.1 Europe Urokinase Market Size YoY Growth 2020-2031

8.2 Europe Urokinase Market Facts & Figures by Country

8.2.1 Europe Urokinase Sales by Country (2020-2031)

8.2.2 Europe Urokinase Revenue by Country (2020-2031)

8.3 Europe Urokinase Sales by Type (2020-2025)

8.4 Europe Urokinase Sales by Application (2020-2025)

9 Latin America

9.1 Latin America Urokinase Market Size YoY Growth 2020-2031

9.2 Latin America Urokinase Market Facts & Figures by Country

9.2.1 Latin America Urokinase Sales by Country (2020-2031)

9.2.2 Latin America Urokinase Revenue by Country (2020-2031)

9.3 Latin America Urokinase Sales by Type (2020-2025)

9.4 Latin America Urokinase Sales by Application (2020-2025)

10 Middle East and Africa

10.1 Latin America Urokinase Market Size YoY Growth 2020-2031

10.2 Middle East and Africa Urokinase Market Facts & Figures by Country

10.2.1 Middle East and Africa Urokinase Sales by Country (2020-2031)

10.2.2 Middle East and Africa Urokinase Revenue by Country (2020-2031)

10.3 Middle East and Africa Urokinase Sales by Type (2020-2025)

10.4 Middle East and Africa Urokinase Sales by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

11.1 Urokinase Supply Chain Analysis

11.2 Urokinase Key Raw Materials and Upstream Suppliers

11.3 Urokinase Clients Analysis

11.4 Urokinase Sales Channel and Sales Model Analysis

11.4.1 Urokinase Distribution Channel Analysis: Indirect Sales VS Direct Sales

11.4.2 Urokinase Distribution Channel Analysis: Online Sales VS Offline Sales

11.4.3 Urokinase Distributors

12 Urokinase Market Dynamics

12.1 Urokinase Industry Trends

12.2 Urokinase Market Drivers

12.3 Urokinase Market Challenges

12.4 Urokinase Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation

14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources

14.2 Author Details

14.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Urokinase Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Urokinase Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Urokinase Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Urokinase Sales by Region (2020-2025) & (BIU)

Table 5. Global Urokinase Sales Forecast by Region (2026-2031) & (BIU)

Table 6. Global Urokinase Revenue by Region (2020-2025) & (US$ Million)

Table 7. Global Urokinase Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 8. Global Urokinase Sales Volume by Type (2020-2025) & (BIU)

Table 9. Global Urokinase Sales Volume by Type (2026-2031) & (BIU)

Table 10. Global Urokinase Revenue by Type (2020-2025) & (US$ Million)

Table 11. Global Urokinase Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 12. Global Urokinase Sales Volume by Application (2020-2025) & (BIU)

Table 13. Global Urokinase Sales Volume by Application (2026-2031) & (BIU)

Table 14. Global Urokinase Revenue by Application (2020-2025) & (US$ Million)

Table 15. Global Urokinase Revenue by Application (2026-2031) & (US$ Million)

Table 16. Global Urokinase Sales by Manufacturer (2020-2025) & (BIU)

Table 17. Global Urokinase Sales Share by Manufacturer (2020-2025)

Table 18. Urokinase Revenue by Manufacturer (2020-2025) & (US$ Million)

Table 19. Urokinase Revenue Share by Manufacturer (2020-2025)

Table 20. Key Manufacturers Urokinase Price (2020-2025) & (US$/MIU)

Table 21. Ranking of Global Top Urokinase Manufacturers by Revenue (US$ Million) in 2024

Table 22. Global Urokinase Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 23. Global Urokinase by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urokinase as of 2024)

Table 24. Urokinase Manufacturers Manufacturing Base Distribution and Headquarters

Table 25. Date of International Manufacturers Enter into Urokinase Market

Table 26. Manufacturers Urokinase Product Type and Application

Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 28. Syner-Med Company Information

Table 29. Syner-Med Description and Business Overview

Table 30. Syner-Med Urokinase Product

Table 31. Syner-Med Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)

Table 32. Syner-Med Sales Proportion of Urokinase by Product in 2024

Table 33. Syner-Med Sales Proportion of Urokinase by Application in 2024

Table 34. Syner-Med Sales Proportion of Urokinase by Geographic Area in 2024

Table 35. Syner-Med Recent Developments

Table 36. Wanhua Biochem Company Information

Table 37. Wanhua Biochem Description and Business Overview

Table 38. Wanhua Biochem Urokinase Product

Table 39. Wanhua Biochem Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)

Table 40. Wanhua Biochem Sales Proportion of Urokinase by Product in 2024

Table 41. Wanhua Biochem Sales Proportion of Urokinase by Application in 2024

Table 42. Wanhua Biochem Sales Proportion of Urokinase by Geographic Area in 2024

Table 43. Wanhua Biochem Recent Developments

Table 44. Jiangxi Haoran Bio-Pharma Company Information

Table 45. Jiangxi Haoran Bio-Pharma Description and Business Overview

Table 46. Jiangxi Haoran Bio-Pharma Urokinase Product

Table 47. Jiangxi Haoran Bio-Pharma Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)

Table 48. Jiangxi Haoran Bio-Pharma Sales Proportion of Urokinase by Product in 2024

Table 49. Jiangxi Haoran Bio-Pharma Sales Proportion of Urokinase by Application in 2024

Table 50. Jiangxi Haoran Bio-Pharma Sales Proportion of Urokinase by Geographic Area in 2024

Table 51. Jiangxi Haoran Bio-Pharma Recent Developments

Table 52. Jiangsu Aidea Pharmaceutical Company Information

Table 53. Jiangsu Aidea Pharmaceutical Description and Business Overview

Table 54. Jiangsu Aidea Pharmaceutical Urokinase Product

Table 55. Jiangsu Aidea Pharmaceutical Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)

Table 56. Jiangsu Aidea Pharmaceutical Sales Proportion of Urokinase by Product in 2024

Table 57. Jiangsu Aidea Pharmaceutical Sales Proportion of Urokinase by Application in 2024

Table 58. Jiangsu Aidea Pharmaceutical Sales Proportion of Urokinase by Geographic Area in 2024

Table 59. Jiangsu Aidea Pharmaceutical Recent Developments

Table 60. Techpool Company Information

Table 61. Techpool Description and Business Overview

Table 62. Techpool Urokinase Product

Table 63. Techpool Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)

Table 64. Techpool Sales Proportion of Urokinase by Product in 2024

Table 65. Techpool Sales Proportion of Urokinase by Application in 2024

Table 66. Techpool Sales Proportion of Urokinase by Geographic Area in 2024

Table 67. Techpool Recent Developments

Table 68. Microbic Biosystems Company Information

Table 69. Microbic Biosystems Description and Business Overview

Table 70. Microbic Biosystems Urokinase Product

Table 71. Microbic Biosystems Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)

Table 72. Microbic Biosystems Sales Proportion of Urokinase by Product in 2024

Table 73. Microbic Biosystems Sales Proportion of Urokinase by Application in 2024

Table 74. Microbic Biosystems Sales Proportion of Urokinase by Geographic Area in 2024

Table 75. Microbic Biosystems Recent Developments

Table 76. LIVZON Company Information

Table 77. LIVZON Description and Business Overview

Table 78. LIVZON Urokinase Product

Table 79. LIVZON Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)

Table 80. LIVZON Sales Proportion of Urokinase by Product in 2024

Table 81. LIVZON Sales Proportion of Urokinase by Application in 2024

Table 82. LIVZON Sales Proportion of Urokinase by Geographic Area in 2024

Table 83. LIVZON Recent Developments

Table 84. North America Urokinase Sales by Country (2020-2025) & (BIU)

Table 85. North America Urokinase Sales by Country (2026-2031) & (BIU)

Table 86. North America Urokinase Revenue by Country (2020-2025) & (US$ Million)

Table 87. North America Urokinase Revenue by Country (2026-2031) & (US$ Million)

Table 88. North America Urokinase Sales by Type (2020-2025) & (BIU)

Table 89. North America Urokinase Sales by Application (2020-2025) & (BIU)

Table 90. Asia-Pacific Urokinase Sales by Region (2020-2025) & (BIU)

Table 91. Asia-Pacific Urokinase Sales by Region (2026-2031) & (BIU)

Table 92. Asia-Pacific Urokinase Revenue by Region (2020-2025) & (US$ Million)

Table 93. Asia-Pacific Urokinase Revenue by Region (2026-2031) & (US$ Million)

Table 94. Asia-Pacific Urokinase Sales by Type (2020-2025) & (BIU)

Table 95. Asia-Pacific Urokinase Sales by Application (2020-2025) & (BIU)

Table 96. Europe Urokinase Sales by Country (2020-2025) & (BIU)

Table 97. Europe Urokinase Sales by Country (2026-2031) & (BIU)

Table 98. Europe Urokinase Revenue by Country (2020-2025) & (US$ Million)

Table 99. Europe Urokinase Revenue by Country (2026-2031) & (US$ Million)

Table 100. Europe Urokinase Sales by Type (2020-2025) & (BIU)

Table 101. Europe Urokinase Sales by Application (2020-2025) & (BIU)

Table 102. Latin America Urokinase Sales by Country (2020-2025) & (BIU)

Table 103. Latin America Urokinase Sales by Country (2026-2031) & (BIU)

Table 104. Latin America Urokinase Revenue by Country (2020-2025) & (US$ Million)

Table 105. Latin America Urokinase Revenue by Country (2026-2031) & (US$ Million)

Table 106. Latin America Urokinase Sales by Type (2020-2025) & (BIU)

Table 107. Latin America Urokinase Sales by Application (2020-2025) & (BIU)

Table 108. Middle East and Africa Urokinase Sales by Country (2020-2025) & (BIU)

Table 109. Middle East and Africa Urokinase Sales by Country (2026-2031) & (BIU)

Table 110. Middle East and Africa Urokinase Revenue by Country (2020-2025) & (US$ Million)

Table 111. Middle East and Africa Urokinase Revenue by Country (2026-2031) & (US$ Million)

Table 112. Middle East and Africa Urokinase Sales by Type (2020-2025) & (BIU)

Table 113. Middle East and Africa Urokinase Sales by Application (2020-2025) & (BIU)

Table 114. Urokinase Key Raw Materials, Industry Status and Trend

Table 115. Urokinase Key Raw Materials and Upstream Suppliers

Table 116. Urokinase Clients Status and Trend

Table 117. Urokinase Typical Clients

Table 118. Urokinase Distributors

Table 119. Urokinase Market Trends

Table 120. Urokinase Market Drivers

Table 121. Urokinase Market Challenges

Table 122. Urokinase Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Urokinase Product Picture

Figure 2. Global Urokinase Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Urokinase Sales Market Share by Type in 2024 & 2031

Figure 4. Urokinase Powder Product Picture

Figure 5. Urokinase Solution Product Picture

Figure 6. Global Urokinase Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 7. Global Urokinase Sales Market Share by Application in 2024 & 2031

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Others

Figure 11. Urokinase Report Years Considered

Figure 12. Global Urokinase Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Urokinase Market Size 2020-2031 (US$ Million)

Figure 14. Global Urokinase Sales 2020-2031 (BIU)

Figure 15. Global Urokinase Sales Market Share Forecast by Region (2020-2031)

Figure 16. Global Urokinase Revenue Market Share by Region (2020-2031)

Figure 17. Global Urokinase Sales Market Share Forecast by Type (2020-2031)

Figure 18. Global Urokinase Revenue Market Share Forecast by Type (2020-2031)

Figure 19. Urokinase Average Selling Price (ASP) by Type (2020-2025) & (US$/MIU)

Figure 20. Global Urokinase Sales Market Share Forecast by Application (2020-2031)

Figure 21. Global Urokinase Revenue Market Share Forecast by Application (2020-2031)

Figure 22. Urokinase Average Selling Price (ASP) by Application (2020-2025) & (US$/MIU)

Figure 23. Urokinase Powder of Urokinase Revenue Market Share by Application, 2024 VS 2031

Figure 24. Urokinase Solution of Urokinase Revenue Market Share by Application, 2024 VS 2031

Figure 25. Global Urokinase Sales Share by Manufacturer in 2024

Figure 26. Urokinase Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 27. Urokinase Powder Market Sales Proportion by Manufacturer in 2024

Figure 28. Urokinase Solution Market Sales Proportion by Manufacturer in 2024

Figure 29. North America Urokinase Revenue 2020-2031 (US$ Million)

Figure 30. North America Urokinase Sales Market Share by Type (2020-2025)

Figure 31. North America Urokinase Sales Market Share by Application (2020-2025)

Figure 32. Asia-Pacific Urokinase Revenue 2020-2031 (US$ Million)

Figure 33. Asia-Pacific Urokinase Sales Market Share by Region (2020-2031)

Figure 34. Asia-Pacific Urokinase Revenue Market Share by Region (2020-2031)

Figure 35. Asia-Pacific Urokinase Sales Market Share by Type (2020-2025)

Figure 36. Asia-Pacific Urokinase Sales Market Share by Application (2020-2025)

Figure 37. Europe Urokinase Revenue Growth Rate 2020-2031 (US$ Million)

Figure 38. Europe Urokinase Sales Market Share by Country (2020-2031)

Figure 39. Europe Urokinase Revenue Market Share by Country (2020-2031)

Figure 40. Europe Urokinase Sales Market Share by Type (2020-2025)

Figure 41. Europe Urokinase Sales Market Share by Application (2020-2025)

Figure 42. Latin America Urokinase Revenue Growth Rate 2020-2031 (US$ Million)

Figure 43. Latin America Urokinase Sales Market Share by Country (2020-2031)

Figure 44. Latin America Urokinase Revenue Market Share by Country (2020-2025)

Figure 45. Latin America Urokinase Sales Market Share by Type (2020-2025)

Figure 46. Latin America Urokinase Sales Market Share by Application (2020-2025)

Figure 47. Middle East and Africa Urokinase Revenue Growth Rate 2020-2031 (US$ Million)

Figure 48. Middle East and Africa Urokinase Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Urokinase Revenue Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Urokinase Sales Market Share by Type (2020-2025)

Figure 51. Middle East and Africa Urokinase Sales Market Share by Application (2020-2025)

Figure 52. Urokinase Supply Chain (Upstream and Downstream Market)

Figure 53. Global Production Market Share of Urokinase Raw Materials by Region in 2024

Figure 54. Urokinase Distribution Channels

Figure 55. Global Urokinase Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 56. Global Urokinase Percentage 2020-2031: Online Sales VS Offline Sales

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 5.2% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

What was the global market size of Urokinase in 2031? shouQi

What was the global market size of Urokinase in 2025? shouQi

Which companies rank high in the global Urokinase market? shouQi

What is the annual compound growth rate of the global Urokinase market size from 2025 to 2031? shouQi

Related Reports

Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Urokinase market size was US$ 82.09 million in 2025 and is forecast to reach a readjusted size of US$ 120 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 77
USD 4250.00
(Single User License)
Global Urokinase Market Research Report 2026
The global Urokinase market was valued at US$ 82.09 million in 2025 and is anticipated to reach US$ 120 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 116
USD 2900.00
(Single User License)
Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Urokinase was estimated to be worth US$ 82.09 million in 2025 and is projected to reach US$ 120 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 110
USD 3950.00
(Single User License)
Global Urokinase Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Urokinase market is projected to grow from US$ 49.8 million in 2024 to US$ 70.6 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 147
USD 4900.00
(Single User License)
Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Urokinase market size was US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 79
USD 4250.00
(Single User License)
Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Urokinase was estimated to be worth US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 95
USD 3950.00
(Single User License)
Global Urokinase Market Research Report 2025
The global market for Urokinase was valued at US$ 49.8 million in the year 2024 and is projected to reach a revised size of US$ 70.6 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published Date: 2025-01-16
Pages: 79
USD 2900.00
(Single User License)
Global Urokinase Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published Date: 2024-04-17
Pages: 142
USD 5600.00
(Single User License)
Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published Date: 2024-04-16
Pages: 137
USD 5900.00
(Single User License)
Global Urokinase Market Insights, Forecast to 2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published Date: 2024-04-07
Pages: 89
USD 4900.00
(Single User License)

Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Urokinase market size was US$ 82.09 million in 2025 and is forecast to reach a readjusted size of US$ 120 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 77
USD 4250.00 (Single User License)
Global Urokinase Market Research Report 2026
The global Urokinase market was valued at US$ 82.09 million in 2025 and is anticipated to reach US$ 120 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-01-04
Pages: 116
USD 2900.00 (Single User License)
Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Urokinase was estimated to be worth US$ 82.09 million in 2025 and is projected to reach US$ 120 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-01-04
Pages: 110
USD 3950.00 (Single User License)
Global Urokinase Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Urokinase market is projected to grow from US$ 49.8 million in 2024 to US$ 70.6 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 147
USD 4900.00 (Single User License)
Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Urokinase market size was US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 79
USD 4250.00 (Single User License)
Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Urokinase was estimated to be worth US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 95
USD 3950.00 (Single User License)
Global Urokinase Market Research Report 2025
The global market for Urokinase was valued at US$ 49.8 million in the year 2024 and is projected to reach a revised size of US$ 70.6 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published: 2025-01-16
Pages: 79
USD 2900.00 (Single User License)
Global Urokinase Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published: 2024-04-17
Pages: 142
USD 5600.00 (Single User License)
Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published: 2024-04-16
Pages: 137
USD 5900.00 (Single User License)
Global Urokinase Market Insights, Forecast to 2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published: 2024-04-07
Pages: 89
USD 4900.00 (Single User License)